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OBJECTIVES This study assessed the degree of endothelial dysfunction in post-acute myocardial infarction
(AMI) and its subsequent status in the infarct-related artery (IRA) in patients treated with
thrombolysis.
BACKGROUND Coronary flow reserve alterations in the IRA after thrombolysis have been described, but the
endothelium-dependent vasomotion has not been investigated, to date.
METHODS Endothelial function in patients after thrombolysis was assessed by infusion of acetylcholine
(ACh) at increasing doses in the IRA. Diameter changes in the distal segments were
evaluated using quantitative coronary angiography. Patients with coronary atherosclerosis
constituted the control group. Clinical variables, electrocardiography and biochemical
markers were used to determine the timing of reperfusion and the extent of the infarct.
Patients in the AMI group were re-evaluated one year later.
RESULTS In the initial assessment, 16 patients showed a vasoconstriction response to ACh in the IRA
compared to the control group (20  21% vs. 4  4%; p  0.01). Significant correlations
between the degree of vasoconstriction and maximum value of the creatine kinase-MB
fraction and number of new Q waves were observed. Of the 12 patients re-evaluated, 4 had
complete occlusion of the IRA. In the remaining eight patients with patent artery, an
improvement in response to ACh was observed relative to the initial study (3  11%, vs.
19  15%, p  0.05).
CONCLUSIONS In patients with AMI treated with thrombolysis, severe endothelial dysfunction in the IRA
is observed early. In patients who retain patency of the IRA, the endothelial dysfunction
improves during the follow-up and suggests a component of stunned endothelium in the first
few days post-AMI. (J Am Coll Cardiol 2002;40:257–65) © 2002 by the American
College of Cardiology Foundation
Endothelial dysfunction is an initial event in the develop-
ment of atherosclerosis and can contribute to the progres-
sion of the disease (1,2). The endothelium plays a predom-
inant role in circulatory homeostasis via the liberation of
various vasoactive substances such as nitric oxide, prostacy-
clins and endothelins (3). Nitric oxide, apart from its
vasodilation action, inhibits plaque aggregation, adhesion of
leukocytes and the proliferation of smooth muscle cells (4).
The functional reaction of the vascular endothelium
under determinate conditions of ischemia is complex. In
animal models, the presence of endothelial dysfunction
during episodes of ischemia and reperfusion has been
documented (5,6). In post-acute myocardial infarction
(AMI) patients with thrombolytic treatment, alterations in
coronary flow reserve have been noted (7,8). However, to
date, there have been no studies that have evaluated the state
of endothelial function in the infarct-related artery (IRA)
after thrombolysis, and whether there is a relationship with
the extent of the infarct and the timing of reperfusion.
Studies have documented that the coronary endothelial
function can improve in different situations (9–13), but it is
not known whether endothelial dysfunction after ischemia
reperfusion is a transient phenomenon.
The present study was conducted in a series of patients
with AMI treated with thrombolytic agents to assess the
state of endothelial function early in the IRA, its relation-
ship with the extent of the infarct and the timing of
reperfusion, and the coronary endothelial function at one
year of follow-up.
METHODS
Patients. Initially, 29 consecutive patients who presented
with an AMI with indication of fibrinolysis and who were
admitted into the coronary care unit of our hospital were
included in the study. All were treated with aspirin and
streptokinase (1.5  106 IU) or recombinant tissue-type
plasminogen activator (100 mg in an accelerated manner)
plus intravenous heparin. Exclusion criteria were a prior
From the Servei de Cardiologia, Hospital de Bellvitge, Universitat de Barcelona,
Barcelona, Spain. The study was supported, in part, by a grant from the Societat
Catalana de Cardiologia. Dr. Ira`culis is in receipt of a research fellowship from the
Generalitat de Catalunya (CIRIT: 1999Fi-00729).
Manuscript received October 11, 2001; revised manuscript received April 4, 2002,
accepted April 18, 2002.
Journal of the American College of Cardiology Vol. 40, No. 2, 2002
© 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00
Published by Elsevier Science Inc. PII S0735-1097(02)01953-8
history of myocardial infarction (MI) in the same coronary
territory, previous coronary revascularization, insulin-
dependent diabetes mellitus, renal insufficiency or severe
hypertension. The protocol of the study was approved by
the ethics committee of our institution, and all patients
provided informed written consent.
Serial electrocardiograms (ECGs) pre-, immediately
post-, and at 2, 6, 12, 24 and 48 h after thrombolysis were
performed. At baseline and at 15, 30 and 60 min and 2, 4,
6, 12, 24 and 48 h following thrombolysis, the levels of MB
fraction of creatine kinase (CK-MB) and myoglobin were
determined. A questionnaire evaluated the moment of pain
remission. The appearance of post-AMI angina necessitat-
ing vasodilator agents was considered an exclusion criterion.
Coronary angiography and the assessment of endothelial
function were scheduled for between 7 and 10 days post-
AMI.
Estimation of reperfusion. INFARCT SIZE. The time inter-
vals between pain onset, implementation of thrombolysis
and pain remission were recorded. Normalization of the
ST-segment and the appearance of new Q-waves were
analyzed in the serial ECGs. Appearance of arrhythmias on
reperfusion was noted. Serial enzymatic values of CK-MB
and myoglobin (14,15) were measured and from which delta
values (changes with time) were calculated (16); the ratio
(individual value divided by the baseline value), the relative
increase (the difference between the individual value and the
basal value divided by the basal value) and the area under the
curve (AUC) were all analyzed.
Cardiac catheterization and the assessment of endothe-
lial function. All the vasodilation and anticoagulant med-
ications were withdrawn at least 48 h before the hemo-
dynamic study. Coronary angiography was performed via
the percutaneous femoral using an 8F catheter. Heparin
(2,500 IU) was administered at the start of the procedure.
Selective coronary angiograms and left ventriculography
were performed, and the administration of nitroglycerin
(NTG) was avoided. An analysis of the global and segmen-
tal contractility of the left ventricle was conducted. Angio-
graphic criteria of exclusion from the study of endothelial
function were the inability to identify the artery responsible
for the AMI, a Thrombolysis In Myocardial Infarction
(TIMI) flow grade 3, or the presence of a significant
lesion in the left main coronary artery.
On identifying the IRA, an additional 7,500 IU of
heparin was administered. Endothelium-dependent and
-independent coronary vasomotor responses were studied as
described previously (2). The two projections that best
visualize the trajectory of the artery were selected for
analyses (Bicor, Siemens, Munich, Germany). A 2.5/3F
infusion catheter (Transit, Cordis, Miami, Florida) was
advanced over a guidewire (0.014 in.) and placed proximally
to the lesion responsible for the AMI. To preclude wire-
induced coronary spasm, the wire was removed. To deter-
mine baseline vasomotor response, physiologic saline was
infused for 1 min through the catheter, and an angiogram
was recorded. To assess endothelium-dependent coronary
vasomotor response, the saline infusion was replaced by
intracoronary infusion of serial doses of acetylcholine
(ACh), with estimated intracoronary final concentrations of
108 mol/l to 106 mol/l. Because ACh causes
endothelium-dependent vessel relaxation in experimental
models and in humans, a paradoxical vasoconstriction after
the infusion of this substance is an indicator of endothelial
dysfunction (2). The duration of each infusion was 2.5 min
and, at each stage, an angiogram was taken. All angiograms
were performed with identical views and radiographic char-
acteristics. All infusions were delivered at a rate of 2 ml/min
using a precision pump injector (Harvard, Southnatick,
Massachusetts). The final blood concentrations of ACh
were estimated with the assumption that blood flow in the
coronary artery was 80 ml/min (17).
Finally, to evaluate endothelium-independent vasomotor
response, NTG bolus (2 mg) was administered through the
guiding catheter, and an angiogram identical to the others
was performed (2). Throughout the procedures, heart rate,
systemic arterial pressure and ECG were monitored con-
tinuously. All details of the catheterization and radiography
were recorded so as to ensure duplication of the procedures
at the proposed follow-up.
Quantitative coronary analysis. Quantitative coronary an-
giography was performed after the infusion of the saline
solution, at the end of each infusion of ACh and after NTG
bolus. Angiograms were performed in the two orthogonal
projections that best showed the artery of interest, without
overlapping of side branches and with less foreshortening.
Angiograms were obtained on a real-time digital image
acquisition and processing system (Digitron-3, Siemens).
Images were acquired at 25 frames/s with a 512  512 pixel
matrix with 10-bit depth for subsequent computer analysis.
End-diastolic frames were taken for quantification. This
system is based on a modular, fully automated border-
detection algorithm developed by Pope et al. (18) and
described in detail elsewhere. Variability of this method has
been previously reported (19).
Calibration of the system was based on dimensions of the
guiding catheter not filled with contrast medium. Mean
luminal diameters of the segments distal to the lesion
Abbreviations and Acronyms
ACE  angiotensin-converting enzyme
ACh  acetylcholine
AMI  acute myocardial infarction
ANOVA  analysis of variance
AUC  area under the curve
CK-MB  creatine kinase-MB fraction
ECG  electrocardiogram
IRA  infarct-related artery
MI  myocardial infarction
NTG  nitroglycerin
TIMI  Thrombolysis In Myocardial Infarction trial
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responsible in the studied artery were averaged for the two
projections, at baseline, after infusion of stepwise doses of
ACh and after NTG. Mean luminal diameter was deter-
mined in two or three segments (depending on the site of
the culprit lesion, proximal or middle), each of 15 to 20 mm
in length and in relation to anatomical landmarks. The
percentage of change in mean luminal diameter after each
infusion relative to the baseline was noted. All quantitative
measurements were performed by the same investigator
(M. S.). Intraobserver variability was assessed by analyzing a
series of 20 studies (200 repeated measurements in total) at
least three months apart. The intraobserver differences
(mean  2 SD) in luminal diameter were as follows: 2.0 
3.9% for baseline values, 1.8  4.0% after maximal dose of
ACh and 1.7  3.8% after NTG. The intraclass correlation
coefficients (R2) for repeated measurements were 0.95 for
baseline values, 0.96 for maximal-dose ACh values and 0.98
for NTG values. Endothelial dysfunction was defined as a
vasoconstriction of the segment at maximal dose of ACh
beyond the variability of the method of analysis (4%).
Control group. The control group consisted of 12 patients
without antecedents of infarction, with significant single-
vessel disease that had been previously treated with
coronary angioplasty and without restenosis in an angio-
graphic study six months after angioplasty. The assess-
ment of endothelial function was performed in the
previously dilated artery with identical methodology as
the study group of patients.
Endothelial function reevaluation. In the group of pa-
tients post-AMI, the reevaluation of endothelial function
was scheduled for the following year. The patients were
followed in our outpatient clinic. Reassessment of endothe-
lial function was performed under identical conditions as
the first assessment.
Statistical analyses. The SPSS software for Windows
(SPSS Inc., Chicago, Illinois) was used for all analyses. The
results for continuous variables are presented as mean 
SD. Comparisons between two groups were made by the
Student t test for continuous variables and by either the
chi-square test or the Fisher exact test for categorical
variables, as appropriate. Comparison of coronary segment
diameters at different ACh dosages were made by analysis of
variance (ANOVA) for repeated measurements, which is
based on a general linear model for repeated measurements,
with multiple paired comparisons corrected by the Tukey
method, so as to assess the effect of belonging to the treated
or control groups. Interactions between group and coronary
diameter, and between group and the initial and follow-up
percentage of changes in coronary diameter after ACh
infusion, were assessed. Analysis of residuals (dfbeta and
typified dfbeta) was performed. Correlations between quan-
titative variables were conducted by the Pearson correlation
coefficient. Statistical significance was defined as a value of
p  0.05.
RESULTS
Of the 29 patients initially included in the study, 1 died after
thrombolysis and 7 were excluded because of postinfarct
angina that necessitated vasodilator drugs. Of the remaining
21 patients, the coronary angiography demonstrated a
TIMI flow grade 3 in 4 patients and a severe lesion in the
left main coronary artery in 1 patient. Endothelial function
was assessed in the remaining 16 patients.
The baseline characteristics of patients and control group
are presented in Table 1. No statistically significant differ-
ences existed between the groups with respect to age,
gender, prevalence of risk factors and extent of coronary
disease. In the study group, thrombolysis was performed
within 140 60 min from the onset of chest pain. The IRA
was the anterior descending artery in 10 patients (63%),
right coronary artery in 5 (31%) and circumflex in 1 patient
(6%). The left ventricular ejection fraction was greater in the
control group.
Initial study of endothelial function. Assessment of en-
dothelial function was conducted within 9  2 days of the
infarct in the study group. The mean diameter of the arterial
segments analyzed was 2.5  0.5 mm in the post-AMI
group and 2.4  0.5 mm in the control group (p  NS).
Intracoronary infusion of ACh produced a significant vaso-
constriction response indicative of endothelial dysfunction
in the IRA in the group of post-AMI patients (Fig. 1, Table
2). At the maximum concentration of ACh, there was a
mean vasoconstriction of the artery in the group of post-
AMI patients compared to a mean vasodilation response in
the control group (20  21% vs. 4  4%; p  0.01).
Nitroglycerin provoked a similar grade of vasodilation in
both groups (16  3% vs. 11  4%; p  NS), suggesting
that the nonendothelial-dependent vasodilation was con-
served. No significant changes occurred in arterial pressure
or in cardiac rate in the course of ACh administration. No
clinical complications were seen during the procedures.
Correlates of endothelium-dependent vasodilation. The
severity of endothelial dysfunction did not correlate with
vessel size (r  0.12; p  NS). The status of endothelial
function of the IRA did not correlate significantly with any
of the following variables measured to determine the timing
of reperfusion: value of myoglobin at 90 min (r  0.35; p 
NS), ratio and relative increment of CK-MB (r  0.23;
p NS and r0.25; p NS, respectively) and ratio and
relative increment of myoglobin (r  0.30; p  NS and
r  0.30; p  NS, respectively). Conversely, the initial
endothelial dysfunction correlated significantly with param-
eters indicative of the extent of infarct. The percentage of
diameter change at the maximum dosage of ACh correlated
with the maximum value of the CK-MB (r  0.53; p 
0.05), the AUC of CK-MB (r0.49; p 0.05) and with
the number of new “Q” waves (r  0.62; p  0.04).
Reassessment study of endothelial function in the IRA in
follow-up. During the follow-up, patients were asked to
follow secondary prevention measures, and all patients were
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treated with aspirin. Additionally, two had angiotensin-
converting enzyme (ACE) inhibitors, four had beta-
blockers and three had hypolipidemic drugs prescribed.
Cholesterol levels were 5.46 mmol/l and 5.20 mmol/l in the
first and second study, respectively.
Of the 16 patients in whom we had performed the initial
endothelial function study, 4 asymptomatic patients decided
not to participate in the second study. Of the 12 remaining
patients, the second study showed complete occlusion of the
IRA in 4 patients. As such, the reevaluation of endothelial
function was performed in 8 patients at 12  3 months’
post-AMI. The ejection fraction was 51 12% (pNS vs.
the first study). In those patients who retained permeability
of the artery, a significant improvement in the grade of
Table 1. Baseline Characteristics of the Patients With AMI and the Control Group
(Percentages of the Overall Study Group in Parentheses)
Post-AMI Patients
(n  16)
Control Group
(n  12) p Value
Age (yrs) 65  8 61  6 NS
Male 14 (87) 11 (91) NS
Smoking habit 7 (44) 8 (66) NS
Hypertension 6 (37) 6 (50) NS
Noninsulin-dependent diabetes 3 (19) 2 (16) NS
Dyslipidemia 4 (25) 6 (50) NS
Number of diseased vessels 1.2  0.7 1.1  0.4* NS
Arteries assessed
Descending anterior artery 10 (63) 10 (83)
Right coronary artery 5 (31) 2 (17)
Circumflex artery 1 (6)
Stenosis (%) 62  30 31  6 0.03
Left ventricular ejection fraction (%) 50  17 62  10 0.04
Site of the AMI —
Anterior-lateral 10 (63)
Inferior-posterior 6 (37)
Thrombolytic agent —
Tissue plasminogen activator 11 (69)
Streptokinase 5 (31)
Time to thrombolysis (min) 140  60 —
Maximum value of CK-MB (kat/l) 6.06  3.21 —
Maximum value of myoglobin (kat/l) 3608  3021 —
Data are presented as mean  SD. *Six months before the endothelial function study.
AMI  acute myocardial infarction; CK-MB  MB fraction of creatine kinase.
Figure 1. Percent change in arterial diameter in response to different doses of acetylcholine (ACh) in post-acute myocardial infarction (AMI) patients and
the control group. At the maximum concentration of ACh the post-AMI patients showed a considerable vasoconstriction response in the infarct-related
artery, indicative of endothelial dysfunction, while the control group showed a slight vasodilation response. Both groups exhibited a vasodilation response
to nitroglycerin (NTG), suggesting that the nonendothelium-dependent vasodilation is conserved.
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endothelial dysfunction was observed (Fig. 2). In the first
study and at the maximum concentration of ACh, an
intense vasoconstriction response was noted, whereas in the
second study and at the same concentration of ACh, a
vasodilation response was observed (19  15% vs. 3 
11%; p  0.04), similar to the response noted in the control
group at the first study (4  4%; p  NS; Fig. 3). No
significant correlations existed between endothelial function
at follow-up and the initial parameters of reperfusion or the
extent of the infarct. Neither was there any relationship
observed between the type and number of drugs received by
each patient during follow-up and the improvement in the
endothelial function. Figure 4 shows the response of the
IRA in one of the patients at the maximum concentration of
ACh in the initial study and in the reevaluation. Five patients
who presented with angina and/or ischemia induced in an
exercise tolerance test were scheduled for angioplasty at the end
of the endothelial function assessment.
DISCUSSION
Our study demonstrates that in the first few days of an AMI
treated with thrombolytic therapy, the IRA has a consider-
able degree of endothelial dysfunction compared to a control
group of patients with coronary artery disease but who had
not experienced a previous infarct. The initial endothelial
dysfunction correlated significantly with parameters indica-
tive of the size of infarct. In patients who retained patency
of the artery, the endothelial function underwent a signifi-
cant improvement in the follow-up year.
To date, there have not been any studies evaluating
endothelial function status in the IRA following thrombol-
ysis. Okamura et al. (20) observed a significant vasoconstric-
tion response to ACh in the IRA between 1 and 24 months
after AMI in patients who had not been treated with
thrombolytic agents. Bridges et al. (21), using factor VIII
von Willebrand factor antigen as a marker of endothelial
dysfunction, observed a significant increase in plasma levels
of the marker in a series of patients following thrombolytic
therapy; this suggested that the ischemia-reperfusion in
patients with AMI would cause a lesion on the endothe-
lium.
Studies in experimental animals indicate that abnormal
vasomotor response after a myocardial infarct could be
related to the liberation of serotonin, thromboxane A or
thrombin, which would induce constriction of the smooth
muscle around the site of the thrombosis or in the distal
segments (22). In contrast, models of ischemia-reperfusion
show that occlusion of the epicardial arteries with subse-
quent reestablishment of the flow can produce a migration
of neutrophils toward the endothelium and the elastic
lamina (23), an accumulation of mastocytes (24) and the
production of superoxide anions.
Human cells are altered substantially during exposure to
hypoxia. Transient expression of preformed proteins stored
within the endothelium promotes leukocyte endothelial cell
interaction and coagulation. Alternatively, in response to
Table 2. Coronary Vasomotor Response (Mean Luminal
Diameter in mm)
Post-AMI Patients
(n  16)
Control Group
(n  12)
Baseline 2.55  0.5 2.48  0.5
ACh 108 2.46  0.4 2.56  0.4
ACh 107 2.43  0.4 2.54  0.5
ACh 106 2.01  0.5*† 2.57  0.4
NTG 2.95  0.5† 2.76  0.5
Data are presented as mean  SD. *p  0.001 with respect to control group. †p 
0.001 with respect to baseline values.
ACh  acetylcholine; NTG  nitroglycerin.
Figure 2. Individual changes in post-acute myocardial infarction patients, in response to the maximum concentration of acetylcholine (ACh) at the time
of the initial study (9  2 days) and one year later. *p  0.04; IRA  infarct-related artery. Data are expressed as mean  SEM.
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tumor necrosis factor, interleukin-1 and interleukin-6, tran-
scriptional activation of several genes is initiated in the
endothelial cells, and translation of specific transcripts into
protein products on the endothelial surface is completed
over the course of several hours. These proteins include
leukocyte adhesion molecules, tissue factor and leukocyte
activators. In this situation there is an increase of adherence
of leukocytes to endothelial cells (25), an up-regulation of
intercellular adhesion molecule, and release of interleukin-
1-alpha, E-selectin and interleukin-8.
Free radicals may induce significant functional alterations
in endothelial cells that promote and extend the inflamma-
tory reaction (26). In particular, free radicals stimulate
platelet-activating factor release from the endothelium,
which in turn can further activate cells in the growing
neutrophil infiltrate in an amplifying feedback loop (27).
Correlates of the initial endothelium-dependent vasodi-
lation. No significant correlations were observed between
the grade of endothelial dysfunction and the noninvasive
parameters of reperfusion that we had measured. Con-
versely, the grade of dysfunction in the first study correlated
with the variables indicative of the extent of myocardial
necrosis. These findings suggest that, confronted with a
situation of ischemia-reperfusion, the coronary endothelium
behaves, functionally, in a poorly specific manner, similar to
the response documented in the myocardium postreperfu-
sion. Crea et al. (8) observed, in patients post-AMI, that
coronary blood flow reserve, soon after successful thrombol-
Figure 3. Response to the maximum concentration of acetylcholine (ACh) in post-acute myocardial infarction (AMI) patients who retained infarct-related
artery (IRA) patency and in the control group. Initial study was at 9  2 days following infarct, and the follow-up was 12  3 months later. A significant
improvement in the endothelial function in the IRA was observed on follow-up. Endothelial function in the IRA at one-year follow-up was similar to the
response detected initially in the control group. Data are expressed as mean  SEM.
Figure 4. Assessment of endothelial function in the infarct-related artery at 10 days and 9 months in the same patient post-acute myocardial infarction.
At the initial assessment (A), there was a considerable vasoconstriction response to the maximum dose of acetylcholine, which indicates a marked endothelial
dysfunction. In the second assessment (B), a vasodilation response to the acetylcholine was observed, which indicates a significant improvement in the grade
of endothelial dysfunction in the infarct-related artery at follow-up.
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ysis, was strikingly variable and extremely low in some
patients despite widely patent epicardial coronary arteries.
Similarly, Ishihara et al. (28) observed a significant alter-
ation of coronary flow reserve at two weeks’ post-AMI
despite successful angioplasty.
Endothelial cell dysfunction occurs moments after reper-
fusion following regional ischemia, and it progresses with
time (29). Endothelium may be more vulnerable to injury
than the myocyte or endothelial injury that might precede
myocyte injury (30). When rendered hypoxic and reoxygen-
ated, endothelial cells become activated to express pro-
inflammatory properties, pro-coagulant factors and vaso-
constrictive agents that increase vasomotor tone (26). These
changes may contribute to the myocardial dysfunction.
Heart failure per se can influence endothelial function due
to a reduced ability of endothelium to synthesize or release
nitric oxide (31). However, it was unlikely in our patients
because the ejection fraction did not change during the
follow-up and, in contrast, the endothelial dysfunction
improved significantly during this period. Also, the reduc-
tion in the ejection fraction was modest, and no patient
showed signs of heart failure during the study.
Endothelial dysfunction changes at follow-up. In the
patients who retained patency of the artery, the endothelial
dysfunction in the IRA had improved dramatically in the
year post-AMI and demonstrated an ACh response similar
to that documented in the noninfarct control group. Our
study demonstrated the capacity of the human endothelium
to recover its function after an episode of ischemia-
reperfusion.
Using positron emission tomography, Uren et al. (7)
investigated 9 patients at one and six months’ postinfarction
who were treated with thrombolysis. They observed that the
severe vasodilator abnormality initially detected, involving
resistant vessels in the infarcted myocardium, improved
during the follow-up. Ishihara et al. (28) documented that
the coronary flow reserve improves during follow-up in
patients after MI. It has also been observed that endothelial
dysfunction induced by the ischemia-reperfusion processes
can be minimized by specific interventions. Ischemic pre-
conditioning in humans (32) and pharmacologic treatment
with ibopamine, captopril and heparin (33,34), prior expo-
sure to peroxinitrite (35) and hepatic hydroxymethyl-
glutaryl-coenzyme A reductase inhibitors (36) have been
shown to preserve endothelial function in animal models.
No specific interventions during follow-up were conducted
in our patients except for the general secondary prevention
measures in patients post-AMI. No significant correlations
were observed between any of these measures and the grade
of improvement in response to ACh and which was, in
general, superior to the improvement documented in studies
with hypolipidemic agents or ACE inhibitors (10–12).
Mechanisms proposed for the improvement in endothe-
lial function during follow-up in patients with patent
arteries are speculative. Following brief periods of ischemic
insult to the myocardium, considerable alterations in the
coronary vasodilation responsiveness without changes in the
structure of the coronary small vessels have been described
(37). Bhagat et al. (38) define endothelial stunning as a
transient endothelial dysfunction that persists after the
injury and takes a long period to recover. Sheridan et al. (39)
documented a reversible dysfunction of pulmonary vasore-
laxation through stunning of vascular endothelial and
smooth muscle cells.
Study limitations. To assess endothelial function in the
IRA accurately, we excluded those patients with TIMI flow
grade 3 as well as those who, for post-AMI angina, were
under vasodilator treatment. These criteria could imply that
the patients included in the study represented a very selected
subgroup of postthrombolysis patients. Nevertheless, these
patients represent 55% of a consecutive series of patients
with AMI treated with thrombolytic agents. Furthermore,
the expected frequency of a patent artery at nine days’
post-AMI despite a noneffective thrombolysis has been
reported as being between 4% to 22% (40,41). Although we
had not used very early angiographic evaluation for deter-
mining the timing of reperfusion (40) we had, nevertheless,
used a series of noninvasive parameters that have been
validated recently (14–16).
It could be argued that the considerable endothelial
dysfunction that we observed early in the IRA was already
present pre-AMI (42). Endothelial dysfunction is more
prevalent in the setting of acute coronary syndrome than in
chronic coronary artery disease. In patients with unstable
angina, severe endothelial dysfunction has been described in
the culprit lesion. However, the coronary artery downstream
from the culprit lesion in these patients shows minor
degrees of vasoreactivity in response to exercise, with a
magnitude similar to the distal segments of patients with
stable angina (43). In contrast, our post-AMI patients
showed a severe endothelial dysfunction downstream from
the culprit lesion, with important differences compared to
the response shown in the distal segments of the control
group, which consisted of patients with stable coronary
artery disease. Furthermore, the documented reversibility
during the follow-up period would also suggest that the
dysfunction was secondary to the infarct.
The relatively reduced number of patients could be a
limitation of the study. Nevertheless, the endothelial re-
sponse in our group of patients was uniform in the initial
assessment and in the assessment at follow-up. To demon-
strate a definite relationship between IRA patency and
endothelial dysfunction, improvement would require a
much larger number of patients. Likewise, even though no
correlation was found, no definite conclusion can be drawn
regarding the influence of the medication received during
the follow-up and improvement in the endothelial function.
Clinical implications. In this study we demonstrate that,
in post-AMI patients treated with thrombolytic agents and
with patent IRA artery, there is severe endothelial dysfunc-
tion and, as such, it is an attractive model in which to
evaluate different forms of intervention so as to preserve
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endothelial function. Aspects that may be addressed could
include hypoxic endothelial cell injury contribution to the
no-reflow phenomenon (26), relationship between the
endothelial-dependent vasodilation in the epicardial arteries
during follow-up, and the endothelium function of the
micro-circulation and its influence in the long-term ventric-
ular dysfunction, as has been suggested previously (44).
Conclusions. In patients with AMI treated with throm-
bolytic agents, an important degree of initial endothelial
dysfunction that correlates with the extent of infarct is
observed. In those patients who retain a patent IRA, the
endothelial dysfunction improves during the follow-up pe-
riod, which suggests a component of stunned endothelium
in the first few days post-AMI.
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